Skip to main content
Premium Trial:

Request an Annual Quote

Genetics Institute Licenses Pangea's Informatics Tools

Premium

OAKLAND, Calif.--Genetics Institute, a research unit of Wyeth-Ayerst Laboratories, has licensed Pangea's bioinformatics tools for use in its genomics-based drug discovery efforts. Pangea said its tools for clustering and aligning expressed-sequence tags (ESTs) will allow Genetics Institute to increase "the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated."

Gordon Wong, senior director of research at Genetics Institute, claimed that his company has developed a leading position in genomics-based drug discovery through its proprietary gene isolation and gene expression monitoring technologies. He said, "Reducing the complexity and redundancy inherent in large EST databases will increase the efficiencies of these technologies and their effectiveness in drug discovery."

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.